GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hansa Biopharma HNSA.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

41.30

+4.66%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Hansa Biopharma

Our reporting

Next results

5 Nov 2026

Due on 5 Nov 2026. Analysts expect earnings of 6.79 a share on revenue of SEK 323.7m.

Past results

Reported against what analysts expected

22 Jul 202623 Apr 202611 Feb 202630 Oct 202517 Jul 202524 Apr 2025
Earnings per share-2.54-1.88-1.62-1.75-2.53-0.55
Forecast-0.33-1.41-1.58-1.76-1.68-2.67
RevenueSEK 47.8mSEK 33.6mSEK 76.0mSEK 30.8mSEK 49.1mSEK 66.3m
ForecastSEK 50.3mSEK 48.3mSEK 40.4mSEK 38.8mSEK 63.2mSEK 70.5m

Key events

  1. 17 Oct 2007Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.